Atherosclerosis, the primary cause of heart disease and
|
|
- Toby Robbins
- 5 years ago
- Views:
Transcription
1 DNA Vaccination Against VEGF Receptor 2 Reduces Atherosclerosis in LDL Receptor Deficient Mice Ramona J. Petrovan, Charles D. Kaplan, Ralph A. Reisfeld, Linda K. Curtiss Objective Similarities between neovascular ingrowth in atherosclerotic plaques and angiogenesis in tumors suggest that antiangiogenic factors that target tumor expansion may prove efficacious in the treatment of atherosclerosis. This study examined whether an oral DNA vaccine against the murine VEGF receptor 2 (Flk-1) with demonstrated antitumor effect through inhibition of pathological neovascularization can prevent or retard progression of atherosclerosis in hyperlipidemic low density lipoprotein receptor deficient (LDLr / ) mice. Methods and Results Vaccination against Flk-1 resulted in T cell activation, suppression of neoangiogenesis, and a marked reduction in atherosclerosis which was independent of hypercholesterolemia in both male and female mice. Immunohistochemical characterization of aortic sinus lesions showed that the decreased lesion area was not associated with reduced plaque stability and had a lower density of microvessels. Conclusions These findings demonstrate for the first time that a DNA vaccine targeting activated endothelial cells in atherosclerotic lesions provides direct atheroprotective effects. (Arterioscler Thromb Vasc Biol. 2007;27: ) Key Words: atherosclerosis vaccination plaque endothelium neovessels Atherosclerosis, the primary cause of heart disease and stroke, is a progressive inflammatory disease of the vessel wall, elicited at sites of lipoprotein accumulation and hemodynamic turbulence. Endothelial activation supports recruitment of leukocytes and plays a central role in the development and progression of the atherosclerotic plaque and its clinical complications. 1 3 In normal arteries the microvasculature is confined to the adventitia and outer media, but a common feature of advanced human atherosclerotic lesions is intimal and subendothelial neovascularization. 4 6 Plaque vessels promote lipid deposition and the recruitment of inflammatory cells into the lesion, 7 9 which is expected to result in lesion growth and a less stable plaque. Long-term treatment of hypercholesterolemic apoe / mice with inhibitors of angiogenesis reduces intimal neovascularization, the abundance of lesion macrophages, and plaque growth, 10,11 suggesting a correlation between plaque angiogenesis, disease progression, and inflammatory cells in atherosclerotic lesions. Despite growing evidence of an association between neovascularization and atherosclerosis, the role of intralesional angiogenesis in the biology of cardiovascular disease, as well as the use of antiangiogenic therapies as atheroprotective strategy, remain controversial (reviewed in 12 ). See page 993 Plaque vascularization is driven by angiogenic growth factors and cytokines, which stimulate endothelial cell migration and proliferation. 5 In particular, the interaction between VEGF and VEGF receptor 2 (KDR, human; Flk-1, mouse) is key to pathologic angiogenesis 13 and has been implicated in the development of atherosclerotic lesions. 14 KDR is strongly expressed both on endothelial cells during angiogenesis and on the luminal endothelium of human atherosclerotic vessels, but not in normal arteries or veins. 15 In the present study, we hypothesized that a therapy that targets activated endothelial cells may have powerful antiatherosclerotic effects. An oral Flk-1 based DNA vaccine controls tumor growth and metastasis in mice by suppressing angiogenesis through a CD8 T cell mediated response against endothelial cells overexpressing Flk-1. 16,17 This vaccination does not affect fertility, hematopoiesis, and neuromuscular performance, and wound healing is only slightly delayed. 16 Vaccination is an especially attractive concept for treatment of atherosclerosis because it is expected to lead to long-lasting protective responses against this chronic disease. Here, we analyzed the effect of T cell directed immunization with the Flk-1 vaccine on lesion development in a model of diet-induced atherosclerosis using LDL receptor deficient (LDLr / ) mice. Materials and Methods Mice and Experimental Protocol LDLr / mice in a C57Bl/6 background were purchased from Jackson Laboratories and bred in-house. In 3 independent experimental studies, 2 with male and 1 with female mice, LDLr / mice Original received September 8, 2006; final version accepted February 2, From the Department of Immunology, The Scripps Research Institute, La Jolla, Calif. Correspondence to Ramona J. Petrovan, PhD, The Scripps Research Institute, Department of Immunology, IMM-17, North Torrey Pines Rd, La Jolla, CA rjpet@scripps.edu 2007 American Heart Association, Inc. Arterioscler Thromb Vasc Biol. is available at DOI: /ATVBAHA
2 1096 Arterioscler Thromb Vasc Biol. May to 10 weeks of age were orally vaccinated 3 times at 2-week intervals by gavage of CFU Salmonella typhimurium carrying either the pcdna3.1 empty vector (Invitrogen) or a pcdna3.1-flk1 construct. 16 In each study, T cell activation and antiangiogenic effects were evaluated in dedicated mice (n 8/group), 2 to 4 weeks after the last vaccination. In all other mice, atherosclerosis was initiated 2 weeks after the final vaccination by feeding the mice (n 14 to 16/group) a proatherogenic high-fat diet (HFD) containing 1.25% cholesterol, 15.8% fat, and no cholate (#94059, Harlan Teklad) for a total of 16 weeks, after which atherosclerosis was assessed (supplemental Figure I). All mouse experiments were performed according to the NIH Guides for the Care and Use of Laboratory Animals and all protocols were approved by the Institutional Animal Care and Use Committee of The Scripps Research Institute. Bacterial Strains and Cell Lines The murine MS1 endothelial cell line was purchased from American Type Culture Collection. Double attenuated S typhimurium (AroA-, dam-) strain RE88, kindly provided by Remedyne Corporation, was transformed with the plasmids by electroporation, as previously described. 16 Analysis of Atherosclerotic Lesions The extent of atherosclerosis was quantified for each mouse in lipid stained en face preparations of the aorta and in cross sections of the aortic sinus, as described. 18 Histological analysis was performed on subsequent aortic sinus sections from 4 mice per group in each experimental study, ie, 12 sections per treatment group, selected to be representative of the group average lesion size. Masson trichrome stain was used to identify collagen within the aortic sinus sections. Macrophage infiltration was visualized with rat anti-mouse MOMA-2 antibody (Serotec), biotinylated secondary antibody, and streptavidin-peroxidase, followed by color reaction with AEC (Vector Labs), and counterstaining with hematoxylin. The percent of lesion area stained blue (trichrome) and red (MOMA-2), respectively, was calculated by digital image analysis. Microvessel staining was performed with rat anti-mouse CD31 (clone MEC 13.3; BD Pharmingen), followed by Alexa 647 goat anti-rat IgG (Invitrogen) and nuclear staining with DAPI. Samples were viewed using a Rainbow Radiance 2100 laser scanning confocal system with a Nikon TE2000-U inverted microscope (Bio-Rad Zeiss). Images were analyzed for quantitative fluorescence using Image Pro Plus 3DS (Media Cybernetics) and Image J (NIH Imaging) software. The total area occupied by vessels was assessed by quantifying the CD31 area in and around each of the 3 valve cusps individually. Evaluation of Antiangiogenic Effects Vaccinated mice were injected s.c. in the sternal region with 0.4 ml of growth factor reduced Matrigel (BD Biosciences), containing 400 ng/ml murine basic fibroblast growth factor (PeproTech). A week later, 2 mice/group were injected with fluorescent Isolectin B4 (Vector Laboratories) and neovascularization of the Matrigel plugs was evaluated by confocal microscopy. For a quantitative analysis of vessel formation, additional 2 mice/group were injected 0.4% Evans Blue and 30 minutes later Matrigel plugs were removed and their dye content determined by colorimetric quantification at 620 nm. Experiments were performed for each independent vaccination study. Figure 1. Suppression of bfgf-induced angiogenesis. Matrigel plugs in mice vaccinated with empty vector control or the Flk-1 construct, as indicated, were examined 7 days after injection. Macroscopic evaluation (A) and confocal microscopy (B) after in vivo staining with fluorescein-labeled Isolectin B4. Representative photographs are shown. Original magnification, 100. C, Colorimetric quantification of vessel growth. Evans blue content of Matrigel plugs after in vivo injection into mice vaccinated with empty vector control (closed bar) or Flk-1 (open bar) is shown (mean SD, n 6). *P Cytokine Release and Cytotoxicity Assays Enzyme-linked immunospot (ELISPOT) assays were performed to measure single-cell cytokine release. Splenocytes, collected 2 to 4 weeks after the last immunization, were cultured overnight with murine endothelial MS1 cells and assayed in triplicates with an IFN- ELISPOT kit (BD Biosciences). MS1 murine endothelial cells expressing full-length Flk-1, or the synthetic FLK 400 peptide (Multiple Peptide Systems) in the presence or absence of an inhibitory rat anti-mouse monoclonal antibody to CD8 (clone 2.43; Biovest International Inc) were used as stimulators, according to the manufacturer s instructions and analyzed by Immunospot Scanalysis. Cytotoxicity was measured and calculated at different effector to target ratios in a standard 4 hour 51 Cr release assay with splenocytes harvested 2 to 3 weeks after the last immunization and subsequent culture for 5 days, as previously described. 16,19 Statistical Analysis All results were expressed as mean SD, except the lesion data where individual values are shown. Statistical difference of extent of atherosclerosis between experimental groups and controls was analyzed using the nonparametric Mann Whitney rank sum test in the Statview SE statistics package (SAS Institute Inc). All other analyses used a two-tailed, unpaired t test. Results Vaccination of LDLr / Mice Against Flk-1 Leads to Suppression of Angiogenesis and a Specific T Cell Response Suppression of angiogenesis after Flk-1 vaccination was demonstrated qualitatively and quantitatively by performing Matrigel assays. Macroscopic analysis revealed a marked reduction in vascularization of the Matrigel plugs after vaccination against Flk-1 (Figure 1A). In vivo staining of the endothelium with fluorescein-labeled Isolectin B4 showed that vessel number and size were decreased after vaccination with the vector encoding Flk-1 compared with control mice (Figure 1B). This difference in blood vessel formation was further demonstrated quantitatively, as i.v. injection of Evans blue revealed lower dye content in Matrigel plugs from mice immunized with the Flk-1 vaccine compared with plugs from mice immunized with the empty vector (Figure 1C). Release of IFN-, a marker of T cell activation in secondary lymphoid tissues was measured to evaluate T cell responses. Splenocytes isolated from immunized mice were analyzed at the single-cell level by ELISPOT assays using as
3 Petrovan et al Atheroprotection With a Flk-1 DNA Vaccine 1097 Figure 3. Reduction of circulating sflk-1 levels. Equal volumes of plasma were pooled from all mice of each treatment group and individual study. Plasma sflk-1 levels (mean SD) of nonvaccinated mice, empty vector, and Flk-1 vaccinated mice, respectively, before (closed bars) and after 16 weeks (open bars) of HFD consumption are shown (n 3). *P Figure 2. T cell activation by the Flk-1 vaccine. A, Splenocytes isolated from mice immunized with empty vector control (closed bars) or the Flk-1 vaccine (open bars) were stimulated overnight with MS1 murine endothelial cells, then restimulated in ELISPOT assays either with MS1 cells expressing full-length Flk-1 or the Flk 400, as shown. The experiment was repeated 4 times with 2 mice per group. Where indicated, 10 g/ml rat anti-mouse CD8 inhibitory monoclonal antibody was added before restimulation (2 mice/group). *P B, Specific lysis of MS1 Flk-1 positive cells by T cells from mice immunized with pcdna3.1-flk1 ( ) compared with mice vaccinated with the empty vector (f). Shown are the means SD of calculated percentage of target cell lysis (n 3). stimulators either Flk-1 positive MS1 murine endothelial cells or the synthetic peptide FLK400, which represents a major epitope recognized by cytotoxic T lymphocytes in mice vaccinated against Flk Production of IFN- was increased in splenocytes from mice immunized with the Flk-1 vaccine when compared with splenocytes from control mice. Addition of an inhibitory monoclonal antibody to CD8 before stimulation specifically blocked the IFN- secretion (Figure 2A), indicating the involvement of CD8 T cells. Antigen-specific cytotoxicity against Flk-1 positive MS1 cells was demonstrated with a standard 51 Cr release assay. Immunizations with the vector encoding Flk-1 led to increased lysis of murine endothelial target cells expressing Flk-1 when compared with control immunized animals (Figure 2B). No measurable cytotoxicity was detected against target cells not expressing Flk-1 (not shown). Taken together these results indicate that vaccination of LDLr / mice against Flk-1 induced a CD8 T cell mediated response that suppressed angiogenesis. Plasma Cholesterol Levels and Distribution Are Not Affected by Vaccination Two weeks after the final vaccination, mice were fed a proatherogenic high-fat, high-cholesterol diet (HFD) for a total of 16 weeks. All mice displayed normal growth rates throughout the study (not shown). As expected, plasma cholesterol levels were greatly elevated in all mice fed the HFD, with significantly higher levels in male mice as compared with their female counterparts at all time points. Importantly, there was no difference in total cholesterol levels between the Flk-1 and empty vector vaccinated mice in any study, indicating that the Flk-1 vaccine had no impact on diet-induced hypercholesterolemia (supplemental Table I). In addition, a similar distribution of lipoprotein cholesterol was found in samples from mice vaccinated with either the Flk-1 construct or the empty vector control, both before and after high-fat feeding, indicating that immunization did not affect cholesterol distribution. (supplemental Figure II). Levels of Circulating Flk-1 Are Lower in Vaccinated Mice To further examine the effect of vaccination against Flk-1 in LDLr / mice, levels of soluble Flk-1 (sflk-1) were assessed in pooled plasma samples from each study group using a mouse sflk-1 ELISA. Recombinant forms of sflk-1 bind to VEGF 20 and mediate anti-tumor effects. 21 More recently, a naturally occurring, truncated form of Flk-1 was detected in mouse and human plasma. This sflk-1, which is secreted or proteolytically cleaved from endothelial cells, retains ligand binding and may therefore play a role in VEGF-mediated biological functions. 22 Two weeks after the last immunization, plasma levels of sflk-1 were similar in nonvaccinated, empty vector treated or Flk-1 vaccinated mice, indicating that immunization did not affect circulating Flk-1 (Figure 3). Although the Flk-1 content in human atherosclerotic vessels 15 and in the vessel wall of hyperlipidemic apoe / mice is reported to be elevated, 23 we did not detect increased plasma levels of sflk-1 in nonvaccinated LDLr / mice and sflk-1 levels were slightly lower in empty vector vaccinated mice after 16 weeks of consuming the HFD. In contrast, mice vaccinated with the Flk-1 construct showed a 50% decline in sflk-1 in the circulation when compared with their plasma levels before HFD consumption (P 0.04). Because endothelial cells constitute a source of circulating sflk-1, 22 this result is consistent with the expected vaccine-induced destruction of
4 1098 Arterioscler Thromb Vasc Biol. May 2007 Figure 4. Decreased atherosclerotic lesion formation. Extent of atherosclerosis was assessed in male (squares) and female (triangles) LDLr / mice after 16 weeks of consuming a HFD which was initiated 2 weeks after the last vaccination with empty vector (closed symbols) or vector encoding Flk-1 (open symbols). A, En face aortic lesion area was expressed as a fraction of total area. B, Aortic sinus lesion area (reported as m 2 ) was calculated as a mean of m sections for each mouse. Values for individual mice are shown, and means for each experimental group are indicated by a horizontal bar. those endothelial cells that are overexpressing Flk-1 in hyperlipidemic LDLr / mice. Vaccination Decreases Atherosclerotic Lesion Size and Microvessel Density Without Plaque Destabilization Progression of atherosclerotic lesions differs between male and female mice and varies slightly between studies performed at different times. Therefore, atherosclerosis was assessed in 3 independent experimental studies, 2 with male and 1 with female mice, 16 weeks after initiation of the HFD, ie, at week 22 of the study. Despite similar total plasma cholesterol levels, formation of aortic atherosclerotic lesions was substantially decreased in mice vaccinated with the Flk-1 construct compared with controls (Figure 4). Although female LDLr / mice developed more extensive aortic sinus lesions than their male counterparts, similar differences in lesion development compared with controls were observed in all three studies, regardless of lesion size. En face lipid staining of the entire length of the aorta as well as analysis of aortic sinus lesion area showed a significant reduction in lesion size after vaccination against Flk-1 in each of the 3 studies analyzed individually (Figure 4) or when data were pooled for each vaccine (not shown). These findings demonstrate that a prophylactic vaccination against proliferating endothelial cells overexpressing Flk-1 can attenuate progression of atherosclerosis in high fat fed LDLr / mice. To determine the effect of vaccination on lesion morphology, aortic sinus lesion areas comprising the entire intima, including lipid cores and fibrotic components, were examined. Histological characterization was performed on sections selected based on their size (nearest to the mean lesion area of each study group) to facilitate a comparison between lesions formed in Flk-1 vaccinated and control mice. As shown in Figure 5A, smaller and fewer lipid cores were present in lesions from mice which received the Flk-1 vaccine as compared with control vaccinated mice. Masson trichrome staining revealed a more uniform collagen matrix in mice vaccinated against Flk-1, but lesional collagen levels were comparable between both male and female mice (not shown). When normalized to percentage of total lesion area, there were no detectable effects of vaccination on collagen content in aortic sinus sections from all mice. MOMA-2 macrophagespecific immunostaining showed that immunization against Flk-1 had no impact on macrophage content of the lesions in any of the study groups, as the mean percentage of all sinus lesions that stained positively for MOMA-2 was comparable (Figure 5A and 5B). Thus, immunohistochemical analysis revealed no changes in plaque stability. To examine the effect of vaccination on microvessel density in and around the atherosclerotic lesions, CD31- stained sections were evaluated by confocal microscopy. In the control mice, the presence of microvessels around the lesion was obvious, whereas in the mice vaccinated against Flk-1 only a few neovessels were detected (Figure 5C). A quantitative analysis showed that CD31-positive areas in the Flk-1 immunized mice were 2.4-fold lower compared with the control mice (Figure 5D). Taken together, these results suggest that Flk-1 based vaccination against activated endothelial cells may lead to a less advanced lesion phenotype. Discussion The present report demonstrates an atheroprotective effect achieved by immunization with a DNA vaccine against the murine VEGF receptor 2, Flk-1. DNA vaccines encoding highly immunogenic viral or bacterial antigens can elicit a strong humoral response. In contrast, relatively weak selfantigens like Flk-1 in the mouse are not capable of producing a measurable antibody response in syngeneic mice (R.A. Reisfeld, unpublished data), but induce a moderate CD8 and/or CD4 T cell response. Our results show that vaccination of LDLr-deficient C57BL/6J mice against Flk-1 did induce activation of CD8 T cells and antigen-specific T cell mediated cytotoxicity against murine endothelial cells (Figure 2) and provide evidence that targeting atherosclerosis through genetic immunization against activated endothelial cells overexpressing Flk-1 translates into diminished growth of plaques in high fat fed LDLr / mice (Figure 4). This result is consistent with the concept that proliferating endothelial cells functionally contribute to active plaque angiogenesis and atherosclerotic lesion progression. 10 However, the spe-
5 Petrovan et al Atheroprotection With a Flk-1 DNA Vaccine 1099 Figure 5. Characterization of aortic sinus atherosclerosis. A, Aortic sinus lesion morphology in mice immunized with empty vector (top) or the Flk-1 vaccine (bottom). Sections were stained with Oil red O for neutral lipids, Masson trichrome (blue stain) for collagen-rich extracellular matrix, and MOMA-2 antibody for macrophages, as indicated. Original magnification, 50. B, Collagen content and MOMA-2 positive macrophages are reported as percentage staining per total aortic sinus lesion area (mean SD) in mice vaccinated with empty vector control (closed bars) or against Flk-1 (open bars). n 12; n.s. indicates not significant. C, Aortic sinus sections from mice vaccinated with either the empty vector control (top) or the Flk1 construct (bottom) were stained with anti-cd31. Microvessels are indicated by arrows. Original magnification, 100. The high-power image (right panel, original magnification, 600 ) of the microvesselrich area (highlighted in left top panel) shows evident neovascularization in mice vaccinated with the empty vector control D) CD31- positive areas are reported as m 2 (mean SD) in mice (n 12) vaccinated with empty vector control (closed bar) or against Flk-1 (open bar). *P cific mechanisms by which DNA vaccination against Flk-1 reduces atherosclerosis remain to be established. Intraplaque neovascularization has been identified as a critical factor in lesion stability and plaque rupture, 6,24 but the consequences of blocking plaque angiogenesis on the inflammatory component of atherosclerosis and on plaque stability are not fully understood. Interestingly, an earlier report demonstrated that in apoe / mice, antibody-blocking of Flk-1 is ineffective against development of neovasculature in lesions or in surrounding adventitia and does not affect progression of atherosclerotic plaques. 25 These results appear to contradict our data, but blockade of receptor signaling by antibody and T cell-mediated removal of receptor-expressing proliferating endothelial cells in different mouse models of experimental atheroma are unlikely to have comparable effects. Our vaccination against Flk-1 quantitatively reduced plaque development but this does not exclude the possibility that it might also cause adverse qualitative changes in plaque morphology, such as increased accumulation of infiltrated leukocytes and release of matrix metalloproteinases that could lead to plaque destabilization. However, our immunohistochemical analysis of representative aortic sinus sections from three independent studies indicated that DNA vaccination against Flk-1 attenuated atherosclerotic lesion development in LDLr / mice without reducing plaque stability. A recent report indicated a correlation between plaque progression, vasa vasorum (VV) neovascularization, and adventitial inflammation in hyperlipidemic apoe / /LDLr / double knockout mice. 26 These mice display severe lesions in the aorta with considerable structural similarity to human atherosclerosis 27 and develop intraplaque vessels that communicate with adventitial VV. 26 We did not assess the microvessel density along the aorta of the vaccinated LDLr / mice, but found that neovascularization in atherosclerotic regions of the aortic sinus in mice vaccinated against Flk-1 was considerably decreased compared with control mice. If intimal neovascularization is indeed a precondition for advanced atheroma development, suppression of initial angiogenesis through removal of proliferating endothelial cells expressing Flk-1 could have led to reduced plaque formation. However, atherosclerotic lesions in the aortic root are initiated at earlier stages of the disease and progress faster than in the aorta, and therefore lesion growth in LDLr / mice might not directly depend on ongoing neovascularization within our experimental time frame. It is widely accepted that there is an enhanced production and release of inflammatory mediators in atherosclerotic lesions and that these mediators not only act to elicit and sustain the local intramural inflammatory response, but also can enter the circulation and induce a systemic inflammatory response. Although our evaluation of lesion morphology revealed no difference in macrophage infiltration relative to total lesion area, it is possible that lesion-specific inflammatory changes induced by the Flk-1 vaccine were primary mediators of the attenuated atherosclerosis development. Moreover, vaccination against Flk-1 could have led to the
6 1100 Arterioscler Thromb Vasc Biol. May 2007 removal of activated endothelial cells at atherosclerotic lesions, thereby eliminating the major promoters of vascular inflammation and thrombosis, which in turn resulted in atheroprotection. Alternatively, alterations in other Flk-1 mediated biological functions of VEGF 13 and/or of the Flk-1 dependent processes in vascular endothelium in response to shear stress 28 may also have contributed to the beneficial effect of the vaccination against Flk-1. Traditional cardiovascular intervention modalities aimed at attenuation of atherogenesis have focused on the reduction of risk factors, 29 but very few modalities are concerned with the plaque itself. This novel approach has the potential to overcome the limitations of currently applied atheroprotective strategies by triggering robust, stable and long-lived, effector cell-mediated antiatherosclerotic immune responses. Our findings provide the first evidence that the Flk-1 based DNA vaccine may represent an additional choice for the treatment of atherosclerosis. Acknowledgments The authors thank Audrey Black, Joshua Bulgrien, and David J. Bonnet for their excellent technical assistance, and Dr William Kioses for his help with the confocal microscopy analysis. Sources of Funding This study was supported by National Institute of Health grants AI and HL07195 (to R.J.P.) and HL (to L.K.C.). None. Disclosures References 1. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med. 1999; 340: Libby P. Inflammation in atherosclerosis. Nature. 2002;420: Hansson GK, Robertson A-KL, Soderberg-Naucler C. Inflammation and Atherosclerosis. Annual Review of Pathology: Mechanisms of Disease. 2006;1: Barger AC, Beeuwkes R 3rd, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. N Engl J Med. 1984;310: Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep. 2001;3: Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V. Neovascularization in human atherosclerosis. Circulation. 2006;113: Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993;171: de Boer OJ, van der Wal AC, Teeling P, Becker AE. Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? Cardiovasc Res. 1999;41: O Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE. Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation. 1996;93: Moulton KS, Heller E, Konerding MA, Flynn E, Palinski W, Folkman J. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999;99: Moulton KS, Vakili K, Zurakowski D, Soliman M, Butterfield C, Sylvin E, Lo KM, Gillies S, Javaherian K, Folkman J. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc Natl Acad Sci U S A. 2003;100: Khurana R, Simons M, Martin JF, Zachary IC. Role of angiogenesis in cardiovascular disease: a critical appraisal. Circulation. 2005;112: Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9: Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation. 1998;98: Belgore F, Blann A, Neil D, Ahmed AS, Lip GY. Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries. J Clin Pathol. 2004;57: Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G, Eliceiri BP, Reisfeld RA. A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med. 2002;8: Pertl U, Wodrich H, Ruehlmann JM, Gillies SD, Lode HN, Reisfeld RA. Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood. 2003;101: Schiller NK, Kubo N, Boisvert WA, Curtiss LK. Effect of gammairradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2001;21: Zhou H, Luo Y, Mizutani M, Mizutani N, Reisfeld RA, Xiang R. T cell-mediated suppression of angiogenesis results in tumor protective immunity. Blood. 2005;106: Roeckl W, Hecht D, Sztajer H, Waltenberger J, Yayon A, Weich HA. Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2. Exp Cell Res. 1998;241: Tseng JF, Farnebo FA, Kisker O, Becker CM, Kuo CJ, Folkman J, Mulligan RC. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice. Surgery. 2002;132: Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D, Jia X, Kerbel RS. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res. 2004;2: Nespereira B, Perez-Ilzarbe M, Fernandez P, Fuentes AM, Paramo JA, Rodriguez JA. Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-e-deficient mice. Atherosclerosis. 2003;171: Virmani R, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko TN, Wrenn SP, Narula J. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25: Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-flt1. Nat Med. 2002;8: Langheinrich AC, Michniewicz A, Sedding DG, Walker G, Beighley PE, Rau WS, Bohle RM, Ritman EL. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/lowdensity lipoprotein(-/-) double knockout mice. Arterioscler Thromb Vasc Biol. 2006;26: McGillicuddy CCJ, Carrier MMJ, Weinberg PPD. Distribution of lipid deposits around aortic branches of mice lacking LDL receptors and apolipoprotein E. Arterioscler Thromb Vasc Biol. 2001;21: Chen KD, Li YS, Kim M, Li S, Yuan S, Chien S, Shyy JY. Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem. 1999;274: Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8:
Quantitative Imaging of Transmural Vasa Vasorum Distribution in Aortas of ApoE -/- /LDL -/- Double Knockout Mice using Nano-CT
Quantitative Imaging of Transmural Vasa Vasorum Distribution in Aortas of ApoE -/- /LDL -/- Double Knockout Mice using Nano-CT M. Kampschulte 1, M.D.; A. Brinkmann 1, M.D.; P. Stieger 4, M.D.; D.G. Sedding
More informationLeptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice
Leptin deficiency suppresses progression of atherosclerosis in apoe-deficient mice Atherosclerosis, 2007 Chiba T, Shinozaki S, Nakazawa T, et al. Present by Sudaporn Pummoung Apolipoprotein E (apoe( apoe)
More informationPathology of Coronary Artery Disease
Pathology of Coronary Artery Disease Seth J. Kligerman, MD Pathology of Coronary Artery Disease Seth Kligerman, MD Assistant Professor Medical Director of MRI University of Maryland Department of Radiology
More informationCoronary Plaque Neovascularization and Hemorrhage: A Potential Target for Plaque Stabilization?
Coronary Plaque Neovascularization and Hemorrhage: A Potential Target for Plaque Stabilization? Aloke V Finn, Emory University Rakesh K. Jain, Massachusetts General Hospital Journal Title: JACC: Cardiovascular
More informationCardiovascular Division, Brigham and Women s Hospital, Harvard Medical School
Low Endothelial Shear Stress Upregulates Atherogenic and Inflammatory Genes Extremely Early in the Natural History of Coronary Artery Disease in Diabetic Hyperlipidemic Juvenile Swine Michail I. Papafaklis,
More informationSupplementary Materials. for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis
Supplementary Materials for Garmy-Susini, et al, Integrin 4 1 signaling is required for lymphangiogenesis and tumor metastasis 1 Supplementary Figure Legends Supplementary Figure 1: Integrin expression
More informationThe aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the
The aorta is an integral part of the cardiovascular system and should not be considered as just a conduit for blood supply from the heart to the limbs and major organs. A range of important pathologies
More informationVulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark
Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem or Systemic Disease Erling Falk, Denmark Vulnerable Plaque Pathophysiology, Detection, and Intervention VP: A Local Problem
More informationSupplemental Table 1. Primer sequences for transcript analysis
Supplemental Table 1. Primer sequences for transcript analysis Primer Sequence (5 3 ) Primer Sequence (5 3 ) Mmp2 Forward CCCGTGTGGCCCTC Mmp15 Forward CGGGGCTGGCT Reverse GCTCTCCCGGTTTC Reverse CCTGGTGTGCCTGCTC
More informationSupplementary Materials for
www.sciencesignaling.org/cgi/content/full/8/389/ra79/dc1 Supplementary Materials for HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P 1 to limit vascular
More informationDetection of carotid plaque neovascularization with Superb Micro-Vascular Imaging
Detection of carotid plaque neovascularization with Superb Micro-Vascular Imaging Yong Qiang Professor Ultrasonic Department, Beijing An-Zhen Hospital, Capital Medical University, China 1. Background Conventional
More informationRole of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD
Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal
More informationTherapeutic Regulation of Plaque Angiogenesis in Atherosclerosis: Pros and Cons
Therapeutic Regulation of Plaque Angiogenesis in Atherosclerosis: Pros and Cons Karen Moulton, M.D. Dept. of Medicine, Cardiology University of Colorado Anschutz Medical Campus Learning Objectives: 1.
More informationMR Imaging of Atherosclerotic Plaques
MR Imaging of Atherosclerotic Plaques Yeon Hyeon Choe, MD Department of Radiology, Samsung Medical Center, Sungkyunkwan University, Seoul MRI for Carotid Atheroma Excellent tissue contrast (fat, fibrous
More informationRole of Inflammatory and Progenitor Cells in Pulmonary Vascular Remodeling: Potential Role for Targeted Therapies. Traditional Hypothesis Stress
3/1/212 Role of Inflammatory and Progenitor Cells in Pulmonary Vascular Remodeling: Potential Role for Targeted Therapies K.R. Stenmark University of Colorado Denver, CO 845 Prominent Fibroproliferative
More informationArteriosclerosis & Atherosclerosis
Arteriosclerosis & Atherosclerosis Arteriosclerosis = hardening of arteries = arterial wall thickening + loss of elasticity 3 types: -Arteriolosclerosis -Monckeberg medial sclerosis -Atherosclerosis Arteriosclerosis,
More informationThe 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories
The 10 th International & 15 th National Congress on Quality Improvement in Clinical Laboratories Cardiac biomarkers in atherosclerosis Najma Asadi MD-APCP Ross and Colleagues in 1973: Response to Injury
More informationPoS(FISBH2006)019. Imaging Vulnerable Plaque A radionuclide approach. H. William Strauss, M.D. 1
A radionuclide approach H. William Strauss, M.D. 1 Section of Nuclear Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021 United States E-mail: straussh@mskcc.org Frontiers in Imaging
More informationNovel Reduction of PCSK9 Expression: Mechanistic Insights into the Anti-Atherosclerotic & Hypolipidemic Effects of Heat Shock Protein 27
Novel Reduction of PCSK9 Expression: Mechanistic Insights into the Anti-Atherosclerotic & Hypolipidemic Effects of Heat Shock Protein 27 Ed O Brien, Jean-Claude Bakala-N Goma, Chunhua Shi Cumming School
More informationHypothesis: Targeting Plaque Angiogenesis in Atherosclerosis
Hypothesis: Targeting Plaque Angiogenesis in Atherosclerosis Karen Moulton, M.D. Dept. of Medicine, Cardiology University of Colorado Anschutz Medical Campus Learning Objectives: 1. Progress of investigations
More informationBone marrow-derived HL mitigates bone marrow-derived CETP-mediated decreases in HDL in mice globally deficient in HL and the LDLr
Bone marrow-derived HL mitigates bone marrow-derived CETP-mediated decreases in HDL in mice globally deficient in HL and the Neil J. Hime, 1,2 Audrey S. Black, David J. Bonnet, and Linda K. Curtiss Department
More informationVEGFR2-Mediated Vascular Dilation as a Mechanism of VEGF-Induced Anemia and Bone Marrow Cell Mobilization
Cell Reports, Volume 9 Supplemental Information VEGFR2-Mediated Vascular Dilation as a Mechanism of VEGF-Induced Anemia and Bone Marrow Cell Mobilization Sharon Lim, Yin Zhang, Danfang Zhang, Fang Chen,
More informationSuppl Video: Tumor cells (green) and monocytes (white) are seeded on a confluent endothelial
Supplementary Information Häuselmann et al. Monocyte induction of E-selectin-mediated endothelial activation releases VE-cadherin junctions to promote tumor cell extravasation in the metastasis cascade
More informationNeovascularization in the wall of large blood vessels may
Loss of Collagen XVIII Enhances Neovascularization and Vascular Permeability in Atherosclerosis Karen S. Moulton, MD; Bjorn R. Olsen, MD, PhD; Silvia Sonn, BA; Naomi Fukai, MD, PhD; David Zurakowski, PhD;
More informationJournal of the American College of Cardiology Vol. 50, No. 24, by the American College of Cardiology Foundation ISSN /07/$32.
Journal of the American College of Cardiology Vol. 50, No. 24, 2007 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2007.07.081
More informationLIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A 2 : EFFECTS OF LOW DENSITY LIPOPROTEIN APHERESIS
LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A 2 : EFFECTS OF LOW DENSITY LIPOPROTEIN APHERESIS Patrick M. Moriarty, M.D., FACP, Director, Atherosclerosis and LDL-Apheresis Center, University of Kansas Medical
More information04RC2. The biology of vulnerable plaques. Jozef L. Van Herck 1, Christiaan J. Vrints 1, Arnold G. Herman 2
04RC2 The biology of vulnerable plaques Jozef L. Van Herck 1, Christiaan J. Vrints 1, Arnold G. Herman 2 1 Department of Cardiology, Antwerp University Hospital, Edegem, Belgium 2 Department of Pharmacology,
More informationONLINE SUPPLEMENT MATERIAL. CD70 limits atherosclerosis and promotes macrophage function.
ONLINE SUPPLEMENT MATERIAL CD7 limits atherosclerosis and promotes macrophage function. Holger Winkels* 1,2, Svenja Meiler* 1,2, Esther Smeets* 2, Dirk Lievens 1, David Engel 3, Charlotte Spitz 1, Christina
More informationSupplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice.
Supplementary Figures: Supplementary Figure S I: Effects of D4F on body weight and serum lipids in apoe -/- mice. Male apoe -/- mice were fed a high-fat diet for 8 weeks, and given PBS (model group) or
More informationInvited Review. Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular diseases
Histol Histopathol (2000) 15: 557-571 Histology and Histopathology Cellular and Molecular Biology Invited Review Vascular smooth muscle cell proliferation in the pathogenesis of atherosclerotic cardiovascular
More informationVWF other roles than hemostasis. Summary 1: VWF & hemostasis synthesis 11/4/16. Structure/function relationship & functions kDa.
VWF other roles than hemostasis Len$ng PJ, Casari C et al JTH 2012 Summary 1: VWF & hemostasis synthesis Structure/function relationship & functions (HMWM) 20.000kDa multimerization propeptide FVIII GPIb
More informationAn increasing body of experimental data suggests that
Correlation of Vasa Vasorum Neovascularization and Plaque Progression in Aortas of Apolipoprotein E / / Low-Density Lipoprotein / Double Knockout Mice Alexander C. Langheinrich, Agata Michniewicz, Daniel
More informationRole of Inflammation in Pulmonary Hypertension
Role of Inflammation in Pulmonary Hypertension K. R. Stenmark University of Colorado Denver, USA Prominent Fibroproliferative Changes are Observed in the Lung Vasculature of Infants With Pulmonary Arterial
More informationFFR and outcome: The mechanistic link
FFR and outcome: The mechanistic link Bernard De Bruyne Cardiovascular Center Aalst Belgium Mechanisms of Plaque Destabilization Stenosis Hemodynamics Thrombotic Occlusion Blood/ Platelets Histopathology
More informationSUPPLEMENTARY INFORMATION
Complete but curtailed T-cell response to very-low-affinity antigen Dietmar Zehn, Sarah Y. Lee & Michael J. Bevan Supp. Fig. 1: TCR chain usage among endogenous K b /Ova reactive T cells. C57BL/6 mice
More informationIntegrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1
Integrin v 3 targeted therapy for Kaposi s sarcoma with an in vitro evolved antibody 1 CHRISTOPH RADER, 2 MIKHAIL POPKOV, JOHN A. NEVES, AND CARLOS F. BARBAS III 2 Department of Molecular Biology and The
More informationAtherosclerosis, a chronic inflammatory process, 1 prominently
B7-1/B7-2 Costimulation Regulates Plaque Antigen Specific T-Cell Responses and Atherogenesis in Low-Density Lipoprotein Receptor Deficient Mice Chiara Buono, MD; Hong Pang, MD; Yasushi Uchida, MD, PhD;
More informationAdipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University
Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,
More informationCANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University
CANCER IMMUNOPATHOLOGY Eryati Darwin Faculty of Medicine Andalas University Padang 18 Mei 2013 INTRODUCTION Tumor: cells that continue to replicate, fail to differentiate into specialized cells, and become
More informationATHEROSCLEROSIS زيد ثامر جابر. Zaid. Th. Jaber
ATHEROSCLEROSIS زيد ثامر جابر Zaid. Th. Jaber Objectives 1- Review the normal histological features of blood vessels walls. 2-define the atherosclerosis. 3- display the risk factors of atherosclerosis.
More informationVitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-e-deficient mice
Atherosclerosis 171 (2003) 67 73 Vitamins C and E downregulate vascular VEGF and VEGFR-2 expression in apolipoprotein-e-deficient mice Beatriz Nespereira a,1, Maitane Pérez-Ilzarbe a,1, Patricia Fernández
More informationDECLARATION OF CONFLICT OF INTEREST. No disclosures
DECLARATION OF CONFLICT OF INTEREST No disclosures micrornas: Role in progression of atherosclerosis Christian Weber Institute for Cardiovascular Prevention (IPEK) Ludwig-Maximilians-University Munich
More informationAtorvastatin Decreases Vascular Endothelial Growth Factor in Patients With Coronary Artery Disease
Journal of the American College of Cardiology Vol. 39, No. 12, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01884-3
More informationWillem J.M. Mulder, Ph.D. Assistant Professor of Radiology Assistant Professor of Gene and Cell Medicine Director Nanomedicine Laboratory
Willem J.M. Mulder, Ph.D. Assistant Professor of Radiology Assistant Professor of Gene and Cell Medicine Director Nanomedicine Laboratory Noordwijkerhout, The Netherlands 17-18 March 2011 Nanometer (10-9
More informationOncolytic Immunotherapy: A Local and Systemic Antitumor Approach
Oncolytic Immunotherapy: A Local and Systemic Antitumor Approach Oncolytic immunotherapy Oncolytic immunotherapy the use of a genetically modified virus to attack tumors and induce a systemic immune response
More informationIn normal vessels, the microvascular network of vasa
Basic Science Reports Angiogenesis Inhibitors Endostatin or TNP-470 Reduce Intimal Neovascularization and Plaque Growth in Apolipoprotein E Deficient Mice Karen S. Moulton, MD; Eric Heller, MS; Moritz
More informationAtherosclerosis is a multifactorial disease, which is regulated
Vaccination Against VEGFR2 Attenuates Initiation and Progression of Atherosclerosis Arnaud D. Hauer, Gijs H.M. van Puijvelde, Niels Peterse, Paula de Vos, Vincent van Weel, Eva J.A. van Wanrooij, Erik
More informationMATERIALS AND METHODS. Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All
MATERIALS AND METHODS Antibodies (Abs), flow cytometry analysis and cell lines Neutralizing antibodies specific to mouse Dll1, Dll4, J1 and J2 were prepared as described. 1,2 All other antibodies used
More informationSupplemental Table I.
Supplemental Table I Male / Mean ± SEM n Mean ± SEM n Body weight, g 29.2±0.4 17 29.7±0.5 17 Total cholesterol, mg/dl 534.0±30.8 17 561.6±26.1 17 HDL-cholesterol, mg/dl 9.6±0.8 17 10.1±0.7 17 Triglycerides,
More informationSantulli G. et al. A microrna-based strategy to suppress restenosis while preserving endothelial function
ONLINE DATA SUPPLEMENTS Santulli G. et al. A microrna-based strategy to suppress restenosis while preserving endothelial function Supplementary Figures Figure S1 Effect of Ad-p27-126TS on the expression
More informationSupplementary Figure 1. Deletion of Smad3 prevents B16F10 melanoma invasion and metastasis in a mouse s.c. tumor model.
A B16F1 s.c. Lung LN Distant lymph nodes Colon B B16F1 s.c. Supplementary Figure 1. Deletion of Smad3 prevents B16F1 melanoma invasion and metastasis in a mouse s.c. tumor model. Highly invasive growth
More informationPlaque angiogenesis and plaque vulnerability. Angiogenesis: Potential implications
ESC Congress 2011 27. 31. August 2011 Paris France Plaque angiogenesis and plaque vulnerability Angiogenesis: Potential implications Johannes Waltenberger, MD, PhD, F.E.S.C. Professor and Chair of Internal
More informationACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS. Choompone Sakonwasun, MD (Hons), FRCPT
ACTIVATION AND EFFECTOR FUNCTIONS OF CELL-MEDIATED IMMUNITY AND NK CELLS Choompone Sakonwasun, MD (Hons), FRCPT Types of Adaptive Immunity Types of T Cell-mediated Immune Reactions CTLs = cytotoxic T lymphocytes
More informationSupplemental Material
Supplemental Material Supplementary Fig. 1. EETs stimulate primary tumor growth. a) Schematic presentation of genetic and pharmacological tools used to manipulate endogenous EET levels. b) Endothelial
More informationResearch Article Cytological Evaluation of Hyaluronic Acid on Wound Healing Following Extraction
Cronicon OPEN ACCESS DENTAL SCIENCE Research Article Cytological Evaluation of Hyaluronic Acid on Wound Healing Following Extraction Gocmen Gokhan 1 *, Gonul O 1, Oktay NS 2, Pisiriciler R 2 and Goker
More informationCD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells
CD34 + VEGFR-3 + progenitor cells have a potential to differentiate towards lymphatic endothelial cells Tan YZ et al. J Cell Mol Med. (2014 Mar;18(3):422-33) Denise Traxler-Weidenauer April 2014 Introduction
More informationMacrophages form functional vascular mimicry channels in vivo. SI Figures and Legend
Macrophages form functional vascular mimicry channels in vivo Authors: *Faith H. Barnett, *Mauricio Rosenfeld, Malcolm Wood, William Kiosses, Yoshihiko Usui, Valentina Marchetti, Edith Aguilar, and Martin
More informationROLE OF INFLAMMATION IN HYPERTENSION. Dr Barasa FA Physician Cardiologist Eldoret
ROLE OF INFLAMMATION IN HYPERTENSION Dr Barasa FA Physician Cardiologist Eldoret Outline Inflammation in CVDs the evidence Basic Science in Cardiovascular inflammation: The Main players Inflammation as
More informationbasic research OPEN Minnesota, USA and 4 Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA
http://www.kidney-international.org & 213 International Society of Nephrology basic research OPEN see commentary on page 234 Adventitial transduction of lentivirus-shrna-vegf-a in arteriovenous fistula
More informationThe Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis
The Process of Angiogenesis & Inhibition of Angiogenesis and/or Lymphangiogenesis Nam Deuk Kim, Ph.D. Pusan National University Contents Part 1. The process of angiogenesis Part 2. The role of angiopoietins
More informationChronic variable stress activates hematopoietic stem cells
SUPPLEMENTARY INFORMATION Chronic variable stress activates hematopoietic stem cells Timo Heidt *, Hendrik B. Sager *, Gabriel Courties, Partha Dutta, Yoshiko Iwamoto, Alex Zaltsman, Constantin von zur
More informationDyslipidemia Endothelial dysfunction Free radicals Immunologic
ATHEROSCLEROSIS Hossein Mehrani Professor of Clinical Biochemistry Definition Atherosclerosis: Is a chronic inflammatory process characterized by plaque formation within the vessel wall of arteries and
More informationBasic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications
12 th Annual Cardiovascular Disease Prevention Symposium February 8, 2013 KEYNOTE ADDRESS Basic Mechanisms of Atherosclerosis and Plaque Rupture: Clinical Implications Ira Tabas, M.D., Ph.D. Richard J.
More informationInflammation plays a major role in atherosclerosis, 1 and
Soluble P-Selectin and the Risk of Future Cardiovascular Events Paul M. Ridker, MD; Julie E. Buring, ScD; Nader Rifai, PhD Background P-selectin, a cell-surface adhesion molecule involved in leukocyte
More information(a) Significant biological processes (upper panel) and disease biomarkers (lower panel)
Supplementary Figure 1. Functional enrichment analyses of secretomic proteins. (a) Significant biological processes (upper panel) and disease biomarkers (lower panel) 2 involved by hrab37-mediated secretory
More informationDECLARATION OF CONFLICT OF INTEREST. No conflicts of interest
DECLARATION OF CONFLICT OF INTEREST No conflicts of interest University Heart Centre Tübingen Angiogenic actions of platelets Meinrad Gawaz, MD, FESC Tübingen, Germany ESC 2011 Paris GPIb GPIb GPVI TxA2
More informationEffects of biological response modifiers in psoriasis and psoriatic arthritis Goedkoop, A.Y.
UvA-DARE (Digital Academic Repository) Effects of biological response modifiers in psoriasis and psoriatic arthritis Goedkoop, A.Y. Link to publication Citation for published version (APA): Goedkoop, A.
More informationCorrelation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer
Correlation between expression and significance of δ-catenin, CD31, and VEGF of non-small cell lung cancer X.L. Liu 1, L.D. Liu 2, S.G. Zhang 1, S.D. Dai 3, W.Y. Li 1 and L. Zhang 1 1 Thoracic Surgery,
More information* This work was supported in part by the Swiss National Science Foundation.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 285, NO. 30, pp. 23496 23505, July 23, 2010 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A. Angiotensin-converting
More informationSupplementary Figure 1. Characterization of human carotid plaques. (a) Flash-frozen human plaques were separated into vulnerable (V) and stable (S),
Supplementary Figure 1. Characterization of human carotid plaques. (a) Flash-frozen human plaques were separated into vulnerable (V) and stable (S), regions which were then quantified for mean fluorescence
More informationHistopathology: Vascular pathology
Histopathology: Vascular pathology These presentations are to help you identify basic histopathological features. They do not contain the additional factual information that you need to learn about these
More informationAs outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the
3 RESULTS As outlined under External contributions (see appendix 7.1), the group of Prof. Gröne at the DKFZ in Heidelberg (Dept. of Cellular and Molecular pathology) contributed to this work by performing
More informationSupplemental figure 1. PDGFRα is expressed dominantly by stromal cells surrounding mammary ducts and alveoli. A) IHC staining of PDGFRα in
Supplemental figure 1. PDGFRα is expressed dominantly by stromal cells surrounding mammary ducts and alveoli. A) IHC staining of PDGFRα in nulliparous (left panel) and InvD6 mouse mammary glands (right
More informationThe humoral immune responses to IBV proteins.
The humoral immune responses to IBV proteins. E. Dan Heller and Rosa Meir The Hebrew University of Jerusalem, Israel COST FA1207 meeting WG2 + WG3, Budapest, Jan. 2015 1 IBV encodes four major structural
More informationFisher et al. Supplemental Figure 1
Supplemental Figure 1 A TNF IL-1 IL-6 CCL2 CCL5 CXCL10 pg/mg total protein 50 30 10 4,000 3,000 2,000 1,000 n.d. 1 1 14,000 12,000 10,000 8,000 6,000 4,000 2,000 6,000,000 CT26 5,000 16,000 B16 4,000 12,000
More informationSupplemental Methods: Histopathology scoring of individual components of Valentino
Supplementary Materials Online: Supplemental Methods: Histopathology scoring of individual components of Valentino synovitis grade and Mankin cartilage pathology scale Hemophilic synovitis was graded 0-10
More informationStewart et al. CD36 ligands promote sterile inflammation through assembly of a TLR 4 and 6 heterodimer
NFκB (fold induction) Stewart et al. ligands promote sterile inflammation through assembly of a TLR 4 and 6 heterodimer a. mrna (fold induction) 5 4 3 2 1 LDL oxldl Gro1a MIP-2 RANTES mrna (fold induction)
More informationMetabolism and Atherogenic Properties of LDL
Metabolism and Atherogenic Properties of LDL Manfredi Rizzo, MD, PhD Associate Professor of Internal Medicine Faculty of Medicine, University of Palermo, Italy & Affiliate Associate Professor of Internal
More informationChapter 7 Conclusions
VII-1 Chapter 7 Conclusions VII-2 The development of cell-based therapies ranging from well-established practices such as bone marrow transplant to next-generation strategies such as adoptive T-cell therapy
More informationT Cell Activation, Costimulation and Regulation
1 T Cell Activation, Costimulation and Regulation Abul K. Abbas, MD University of California San Francisco 2 Lecture outline T cell antigen recognition and activation Costimulation, the B7:CD28 family
More informationSupplementary Materials for
www.sciencesignaling.org/cgi/content/full/8/385/ra70/dc1 Supplementary Materials for The interaction of heparan sulfate proteoglycans with endothelial transglutaminase-2 limits VEGF 165 -induced angiogenesis
More informationA549 and A549-fLuc cells were maintained in high glucose Dulbecco modified
Cell culture and animal model A549 and A549-fLuc cells were maintained in high glucose Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum at 37 C in humidified atmosphere containing
More informationAngiogenesis in myocardial infarction
European Heart Journal (2002) 23, 1604 1608 doi:10.1053/euhj.2002.3312, available online at http://www.idealibrary.com on Angiogenesis in myocardial infarction An acute or chronic process? N. A. Y. Chung,
More informationSupporting Online Material for
www.sciencemag.org/cgi/content/full/1175194/dc1 Supporting Online Material for A Vital Role for Interleukin-21 in the Control of a Chronic Viral Infection John S. Yi, Ming Du, Allan J. Zajac* *To whom
More informationPBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human
Anti-CD19-CAR transduced T-cell preparation PBMC from each patient were suspended in AIM V medium (Invitrogen) with 5% human AB serum (Gemini) and 300 international units/ml IL-2 (Novartis). T cell proliferation
More informationCytokines, adhesion molecules and apoptosis markers. A comprehensive product line for human and veterinary ELISAs
Cytokines, adhesion molecules and apoptosis markers A comprehensive product line for human and veterinary ELISAs IBL International s cytokine product line... is extremely comprehensive. The assays are
More informationTitle: Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events
Title: Smooth muscle cell-specific Tgfbr1 deficiency promotes aortic aneurysm formation by stimulating multiple signaling events Pu Yang 1, 3, radley M. Schmit 1, Chunhua Fu 1, Kenneth DeSart 1, S. Paul
More informationRoles of Flow Mechanics in Vascular Cell Biology in Health and Disease
Roles of Flow Mechanics in Vascular Cell Biology in Health and Disease Shu Chien Dept. of Bioengineering & Medicine UC, San Diego Presented by Ming-Shaung Ju Dept. of Mech. Eng., NCKU, Tainan Background
More informationT Lymphocyte Activation and Costimulation. FOCiS. Lecture outline
1 T Lymphocyte Activation and Costimulation Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline T cell activation Costimulation, the B7:CD28 family Inhibitory receptors of T cells Targeting costimulators for
More informationSupplementary Figures
Supplementary Figures Supplementary Figure 1. NKT ligand-loaded tumour antigen-presenting B cell- and monocyte-based vaccine induces NKT, NK and CD8 T cell responses. (A) The cytokine profiles of liver
More informationChapter 2 (pages 22 33): Cells and Tissues of the Immune System. Prepared by Kristen Dazy, MD, Scripps Clinic Medical Group
Allergy and Immunology Review Corner: Cellular and Molecular Immunology, 8th Edition By Abul K. Abbas, MBBS; Andrew H. H. Lichtman, MD, PhD; and Shiv Pillai, MBBS, PhD. Chapter 2 (pages 22 33): Cells and
More informationImmune Cells in Atherosclerosis Regulatory vs Inflammatory T cells Göran K Hansson
Immune Cells in Atherosclerosis Regulatory vs Inflammatory T cells Göran K Hansson Center for Molecular Medicine Karolinska Institute Stockholm, Sweden DECLARATION OF CONFLICT OF INTEREST Goran Hansson
More informationSupplemental Data. Epithelial-Macrophage Interactions Determine Pulmonary Fibrosis Susceptibility in. Hermansky-Pudlak Syndrome
Page 1 Supplemental Data Epithelial-Macrophage Interactions Determine Pulmonary Fibrosis Susceptibility in Hermansky-Pudlak Syndrome Lisa R. Young, Peter M. Gulleman, Chelsi W. Short, Harikrishna Tanjore,
More informationScott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION
Scott Abrams, Ph.D. Professor of Oncology, x4375 scott.abrams@roswellpark.org Kuby Immunology SEVENTH EDITION CHAPTER 13 Effector Responses: Cell- and Antibody-Mediated Immunity Copyright 2013 by W. H.
More informationSpheroid-based engineering of a human vasculature in mice
Spheroid-based engineering of a human vasculature in mice Abdullah Alajati, Anna M. Laib, Holger Weber, Anja M. Boos, Arne Bartol, Kristian Ikenberg, Thomas Korff, Hanswalter Zentgraf, Cynthia Obodozie,
More informationSupplementary Figure 1: STAT3 suppresses Kras-induced lung tumorigenesis
Supplementary Figure 1: STAT3 suppresses Kras-induced lung tumorigenesis (a) Immunohistochemical (IHC) analysis of tyrosine 705 phosphorylation status of STAT3 (P- STAT3) in tumors and stroma (all-time
More informationLDL Uptake Cell-Based Assay Kit
LDL Uptake Cell-Based Assay Kit Catalog Number KA1327 100 assays Version: 07 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Background... 3 Principle of the Assay...
More informationT and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse
Proc. Natl. Acad. Sci. USA Vol. 94, pp. 4642 4646, April 1997 Medical Sciences T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse HAYES M.
More informationPlaque Imaging: What It Can Tell Us. Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD
Plaque Imaging: What It Can Tell Us Kenneth Snyder, MD, PhD L Nelson Hopkins MD FACS Elad Levy MD MBA FAHA FACS Adnan Siddiqui MD PhD Buffalo Disclosure Information FINANCIAL DISCLOSURE: Research and consultant
More informationThe Angiopoietin Axis in Cancer
Ang2 Ang1 The Angiopoietin Axis in Cancer Tie2 An Overview: The Angiopoietin Axis Plays an Essential Role in the Regulation of Tumor Angiogenesis Growth of a tumor beyond a limiting size is dependent upon
More information